Healthcare -
Biotechnology - NASDAQ - US
$ 1.065
-4.05 %
$ 123 M
Market Cap
-11.83
P/E
CHRS - SHORT-TERM DEBT
Short-term Debt CHRS - Coherus BioSciences, Inc.
2.14 M
LAST VALUE
-21.63%
2 YEAR CAGR
0.00%
5 YEAR CAGR
-6.51%
10 YEAR CAGR